TriLink BioTechnologies Inc. has granted Dr. Aaron Leconte of the WM Keck Science Department of Claremont McKenna, Pitzer and Scripps Colleges a Research Reward for mutant polymerase research.
"The use of DNA biotechnologies is often limited by which DNA polymerases recognize which modified nucleotide analogs," stated Dr. Leconte.
"In my lab, we are working on discovering DNA polymerases with novel substrate recognition to expand the usefulness of modified nucleotides. TriLink is one of the leaders in the synthesis of high-quality, novel nucleotide analogs, and this Research Rewards grant enables us to work on a significantly more diverse set of nucleotide analogs," concluded Dr. Leconte.
"We are pleased that TriLink's modified nucleotide analogs and custom oligonucleotides help advance directed enzyme evolution." commented Richard Hogrefe, CEO of TriLink.
Hogrefe continued, "TriLink continues to expand its portfolio of nucleotide analogs to support researchers like Dr. Leconte, as they push the envelope of science."
TriLink has been proud to support research and education with its Research Reward Program, since the program's inception in 2002.
Over 35 grants have been awarded for research including nucleotide selectivity of error prone RNA viral polymerases, PCR primer design for undergraduate teaching and research, CleanAmp™ Primers for detection of mRNA expression and DNA repair studies of cross-linked DNA.